These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6310036)

  • 21. Cell-mediated immunity in herpes simplex virus-infected mice: H-2 mapping of the delayed-type hypersensitivity response and the antiviral T cell response.
    Nash AA; Phelan J; Wildy P
    J Immunol; 1981 Apr; 126(4):1260-2. PubMed ID: 6259256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response.
    Mitchell BM; Stevens JG
    J Immunol; 1996 Jan; 156(1):246-55. PubMed ID: 8598469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipopolysaccharide-induced suppressor cells for delayed-type hypersensitivity to herpes simplex virus: nature of suppressor cell and effect on pathogenesis of herpes simplex.
    Altmann DM; Blyth WA
    Immunology; 1984 Nov; 53(3):473-80. PubMed ID: 6092271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of murine herpes simplex virus type 1 retinitis in the uninoculated eye by CD4+ T lymphocytes.
    Azumi A; Cousins SW; Kanter MY; Atherton SS
    Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):54-63. PubMed ID: 7905467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-mediated immunity in herpes simplex virus-infected mice: induction, characterization and antiviral effects of delayed type hypersensitivity.
    Nash AA; Field HJ; Quartey-Papafio R
    J Gen Virol; 1980 Jun; 48(Pt 2):351-7. PubMed ID: 6249885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spread of herpes simplex virus type-1 (Miyama +GC strain) to the central nervous system after intraperitoneal inoculation: the role of the myenteric plexus of the gut.
    Irie H; Harada Y; Yoshihashi H; Kimura T; Kojima M; Kataoka M; Saito M; Sugawara Y; Mori W
    Arch Virol; 1989; 105(3-4):247-57. PubMed ID: 2546519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage migration inhibition as a correlate of cell-mediated immunity to herpes simplex virus type 2 in mice.
    Mogensen SC
    Immunobiology; 1982; 162(1):28-38. PubMed ID: 6286467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Split T-cell tolerance in herpes simplex virus-infected mice and its implication for anti-viral immunity.
    Nash AA; Ashford NP
    Immunology; 1982 Apr; 45(4):761-7. PubMed ID: 6279490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection of newborn mice against herpes simplex virus infection by prenatal and postnatal transmission of antibody.
    Hayashi Y; Wada T; Mori R
    J Gen Virol; 1983 May; 64(Pt 5):1007-12. PubMed ID: 6842184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neural spread of herpes simplex virus types 1 and 2 in mice after corneal or subcutaneous (footpad) inoculation.
    Kristensson K; Vahlne A; Persson LA; Lycke E
    J Neurol Sci; 1978 Feb; 35(2-3):331-40. PubMed ID: 632838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression from the herpes simplex virus type 1 latency-associated promoter in the murine central nervous system.
    Smith C; Lachmann RH; Efstathiou S
    J Gen Virol; 2000 Mar; 81(Pt 3):649-62. PubMed ID: 10675402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute ascending necrotizing myelitis in Okinawa caused by herpes simplex virus type 2.
    Iwamasa T; Yoshitake H; Sakuda H; Kamada Y; Miyazato M; Utsumi Y; Nakamura A
    Virchows Arch A Pathol Anat Histopathol; 1991; 418(1):71-5. PubMed ID: 1899169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute ascending necrotizing myelopathy caused by herpes simplex virus type 2.
    Wiley CA; VanPatten PD; Carpenter PM; Powell HC; Thal LJ
    Neurology; 1987 Nov; 37(11):1791-4. PubMed ID: 3670617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Herpes simplex virus infection and damage in the central nervous system: immunomodulation with adjuvant, cyclophosphamide and cyclosporin A.
    Bishop SA; Hill TJ
    Arch Virol; 1991; 116(1-4):57-68. PubMed ID: 1848069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Herpes simplex myelitis as a cause of acute necrotizing myelitis syndrome.
    Folpe A; Lapham LW; Smith HC
    Neurology; 1994 Oct; 44(10):1955-7. PubMed ID: 7936255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease.
    Hill TJ; Field HJ; Blyth WA
    J Gen Virol; 1975 Sep; 28(3):341-53. PubMed ID: 170376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experimental herpetic infection of the CNS with predominant involvement of the spinal cord].
    Kolomiets AG; Votiakov VI; Duboĭskaia GP; Kolomiets ND; Poleshchuk NN
    Vopr Virusol; 1991; 36(1):44-8. PubMed ID: 1858355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1.
    Bukowski JF; Welsh RM
    J Immunol; 1986 May; 136(9):3481-5. PubMed ID: 2420892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection from herpes simplex virus-induced neuropathology in mice showing delayed hypersensitivity tolerance.
    Altmann DM; Blyth WA
    J Gen Virol; 1985 Jun; 66 ( Pt 6)():1297-303. PubMed ID: 3159847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of androgens on paralysis in mice following intravenous inoculation of herpes simplex virus.
    Yirrell DL; Blyth WA; Hill TJ
    J Gen Virol; 1987 Sep; 68 ( Pt 9)():2461-4. PubMed ID: 2821183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.